We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GRF:BMEGrifols, S.A. Class A Analysis

Data as of 2026-07-16 - not real-time

$10.23

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Eagle Capital Growth Fund, Inc. trades at a trailing PE of 8.1, well below the asset‑management industry average of 17.9, and its price‑to‑book ratio of 0.86 suggests a discount to net asset value. The fund delivers an attractive 8.33% dividend yield with a payout ratio of roughly 67%, but the absence of cash and operating cash flow raises questions about long‑term sustainability. Technically, the stock sits above its 20‑day (10.10) and 50‑day (10.07) SMAs, and the MACD histogram is positive, indicating short‑term momentum, yet it remains below the 200‑day SMA (10.45) and near the resistance level of 10.29, implying a neutral longer‑term trend. Volume is trending upward, supporting the bullish technical signals, while the 30‑day volatility of 14.3% and an exceptionally low beta of 0.02 point to modest price swings and limited market correlation. The fund’s valuation appears undervalued relative to peers, but the lack of cash reserves and modest growth (‑2% revenue) suggest caution. Overall, the combination of strong dividend income, low market risk, and discounted valuation makes GRF a potential income‑focused play, provided investors are comfortable with liquidity constraints and dividend sustainability concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above 20‑day and 50‑day SMAs
  • MACD bullish crossover
  • Proximity to resistance and low liquidity

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued PE and P/B relative to industry
  • High dividend yield with moderate payout
  • Low beta and improving volume

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained dividend income potential
  • Discounted valuation but limited cash reserves
  • Neutral long‑term trend below 200‑day SMA

Key Metrics & Analysis

Financial Health

Revenue Growth-2.00%
Profit Margin504.51%
P/E Ratio8.1
ROE10.79%
ROA0.51%
P/B Ratio0.9
Industry P/E17.9

Technical Analysis

TrendNeutral
RSI56.0
Support$9.97
Resistance$10.29
MA 20$10.10
MA 50$10.07
MA 200$10.45
MACDBullish
VolumeIncreasing
Fear & Greed Index93.45

Valuation

GradeUndervalued
TypeValue
Dividend Yield8.33%

Risk Assessment

Beta0.02
Volatility14.27%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.